Serina Therapeutics (SER) Current Assets (2017 - 2026)
Serina Therapeutics (SER) posted Current Assets of $6.1 million for Q4 2025, down 47.12% sequentially from $11.5 million in Q3 2025, and up 7.12% YoY from $5.7 million in Q4 2024.
Serina Therapeutics (SER) Current Assets (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Current Assets for 9 years, with the latest figure at $6.1 million in Q4 2025.
- Quarterly Current Assets rose 7.12% year-over-year to $6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.1 million (up 7.12% YoY) and the FY2025 annual result came in at $6.1 million, up 7.12% from the prior year.
- Current Assets eased to $6.1 million in Q4 2025 per SER's latest filing, from $11.5 million in the prior quarter.
- Over five years, Current Assets peaked at $11.5 million in Q3 2025 and troughed at $1.1 million in Q3 2023.
- A 5-year average of $4.3 million and a median of $2.3 million in 2021 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets jumped 560.52% in 2024, then plunged 35.62% in 2025.
- Over 5 years, Current Assets stood at $2.2 million in 2021, then increased by 9.8% to $2.5 million in 2022, then jumped by 210.6% to $7.6 million in 2023, then slipped by 25.5% to $5.7 million in 2024, then rose by 7.12% to $6.1 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $6.1 million, $11.5 million, and $8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 25.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.03 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | 7.99 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Dec 31, 2024 | 5.68 Mn |
| Sep 30, 2024 | 5.42 Mn |
| Jun 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | 8.94 Mn |
| Dec 31, 2023 | 7.62 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 2.23 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 1.56 Mn |